What is the main business of Contact Pharm?

The main business activity of Contact Pharm focuses on activities of call centres.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 10, 2010.

Where is the headquarters located?

The headquarters is located at: Żeligowskiego 8/10, 90-753 Łódź.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

The company reported a revenue of $546,731 in 2024, which is an increase of 0.4% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $12,054, meaning the company decreased its profit by 81.6%.

What is the largest operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $268,244 in 2024, representing 50% of all operating expenses.

Contact PharmS.K.A.

Activities of call centres

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2010-12-10

Share capital

50 000,00 PLN

Activity description

Contact Pharm operates a specialist contact center for the pharmaceutical industry, offering telemarketing and hotline services. With dozens of dedicated workstations, it reaches more than 10,000 pharmacies across Poland each week, supporting product sales and promotion.

Registered address

Żeligowskiego 8/10, 90-753 Łódź, Poland

Website

contactpharm.pl

Phone

Social media

Electronic delivery address

AE:PL-30158-48623-SCCCR-25

Financials

3 of the last 5 financial statements were filed late.

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 825.29kMedianUSD 276.11kAverageUSD 3.49m

Net profit

This companyUSD 179.94kMedianUSD 4.39kAverageUSD 144.10k

Operating costs

This companyUSD 627.24kMedianUSD 256.54kAverageUSD 3.17m

Assets

This companyUSD 355.57kMedianUSD 132.96kAverageUSD 1.29m

Industry

Bank accounts

Registered as a VAT taxpayer on 2011-01-11.

Alior Bank
98 2490 0005 0000 4530 2967 6341

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
May 19, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$22,248$22,248	Polski Fundusz Rozwoju S.A.
Dec 11, 2018	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$797$797	Łódzka Specjalna Strefa Ekonomiczna S.A.
Nov 20, 2018	De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)	$5,141$5,141	Łódzka Specjalna Strefa Ekonomiczna S.A.

Trademarks

Contact Pharm currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2011.

Mark	Number	Classes	Status	Protected until
CONTACT PHARM(word)	Z.387389	5, 35	Expired	–

Mark	Protected until
CONTACT PHARM(word)	–

General partners

Contact Pharm sp. z o.o.

Manner of representation

The company is represented by the general partner independently.

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Contact.Plsp. z o.o.	$3,631,245.30	contact.pl
Multi Contact Centersp. z o.o.	$2,664,372.63	multicc.pl
Medcare Solutionssp. z o.o.	$1,476,289.01	medcaresolutions.pl
Polcallsp. z o.o.	$1,454,340.71	polcall.pl
Ccig Medsp. z o.o.	$1,089,544.58	ccigmed.pl
BPO Managementsp. z o.o.	$1,016,487.78	bpom.pl
Vocare Bposp. z o.o.	$875,325.79	vocarebpo.pl
ICCsp. z o.o.	$458,319.03	icc.biz.pl
Prepssp. z o.o.	$426,565.88	preps.com.pl
K2 Dystrybucjesp. z o.o.	$262,418.03	k2dystrybucje.pl

Change history

Date	Event
2016-10-07	PKD change (Removed: 10, 11, 18, 20, 21, 22, 23, 26.51.Z, 26.70.Z, 28.25.Z, 28.29.Z, 28.99.Z, 32.50.Z, 33.12.Z, 33.13.Z, 33.14.Z, 33.20.Z, 41, 42, 43, 47.11.Z, 47.19.Z, 47.51.Z, 47.52.Z, 47.59.Z, 47.61.Z, 47.62.Z, 47.72.Z, 47.74.Z, 47.75.Z, 47.78.Z, 47.91.Z, 47.99.Z, 49, 52, 55, 56, 61.10.Z, 61.20.Z, 61.30.Z, 61.90.Z, 62.01.Z, 62.02.Z, 63.99.Z, 64.20.Z, 64.91.Z, 64.92.Z, 64.99.Z, 66.19.Z, 68.10.Z, 68.20.Z, 68.31.Z, 68.32.Z, 70.21.Z, 70.22.Z, 72.11.Z, 72.19.Z, 73.11.Z, 74.10.Z, 74.30.Z, 74.90.Z, 77.29.Z, 77.39.Z, 77.40.Z, 78.10.Z, 82.30.Z, 82.91, 85.59.A, 85.59.B, 86.10.Z, 86.90.A, 86.90.B, 86.90.C, 86.90.D, 86.90.E, 87.90.Z, 92.00.Z, 93.19.Z, 93.29.Z, 95.29.Z, 96.09.Z)
2010-12-10	Entered in the register

FAQ

Last updated: 2026-03-23